 Home > Active Ingredient News > Antitumor Therapy > Gynecol Oncol: The therapeutic effect of Nelatinib in patients with HER2 mutation and metastatic cervical cancer

Gynecol Oncol: The therapeutic effect of Nelatinib in patients with HER2 mutation and metastatic cervical cancer

 Last Update: 2021-04-22
 Source: Internet
 Author: User

Tags

5 3 models

12 2 nm

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

About 5% of cervical cancer patients have somatic HER2 mutations, which are related to poor prognosis.

The study enrolled 16 patients with HER2-mutated, persistent, metastatic/recurrent cervical cancer who had advanced or advanced disease after platinum treatment and received oral neratinib 240 mg/day and loperi in the first cycle.

prevention

The results showed that 10 (62.

In summary, the results of this study indicate that neratinib as a single agent can be used to treat patients with HER2 mutant cervical cancer without new safety incidents.

Original source:

Ana Oaknin,et al.

ncbi.
nlm.
nih.
gov/32723675/" target="_blank" rel="noopener">Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.